MPM BioVentures 2014, L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 72,401 shares at $27.99 ($2.0M) on 2021-09-14, disclosed to the SEC on 2021-09-16.
Open-market sale of $2.0M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.50 | 17,938 | $493K | 24.6% |
| 2 | $27.99 | 3,623 | $101K | 5.0% |
| 3 | $27.99 | 3,623 | $101K | 5.0% |
| 4 | $27.79 | 23,113 | $642K | 32.0% |
| 5 | $27.79 | 23,113 | $642K | 32.0% |
| 6 | $28.15 | 991 |
| $28K |
| 1.4% |
| Total | $27.74 avg | 72,401 | $2.0M | 100% |
| Filing → |
| TRDA | SELL | 2026-08-31 | $616K | — | Filing → |
| TRDA | SELL | 2026-08-26 | $462K | — | Filing → |
| HOWL | SELL | 2025-11-12 | $438K | — | Filing → |